Evidence map›Paper›PMID 32709228›Full record

ArticleBMC public health2020

Is a differentiated care model needed for patients with TB? A cohort analysis of risk factors contributing to unfavourable outcomes among TB patients in two states in South India.

Reynold Washington, Rajaram Subramanian Potty, A Rajesham, T Seenappa, Anil Singarajipura, Reuben Swamickan, Amar Shah, K H Prakash, Arin Kar, Karthikeyan Kumaraswamy and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. A Qualitative Exploration into a Statewide Differentiated TB Care Initiative Aimed at Reducing TB Deaths.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Reynold WashingtonKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Behind KSSIDC Admin. Office, Rajajinagar, Bengaluru, Karnataka, 560044, India.
Rajaram Subramanian PottyKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Behind KSSIDC Admin. Office, Rajajinagar, Bengaluru, Karnataka, 560044, India. rajara999@gmail.com.ORCID http://orcid.org/0000-0002-1232-143X
A RajeshamOffice of the Joint Director (TB), Commissionerate of Health and Family Welfare, Hyderabad, Telangana, India.
T SeenappaOffice of the Joint Director (TB), Lady Willingdon State TB Centre, Bengaluru, Karnataka, India.
Anil SingarajipuraOffice of the Joint Director (TB), Lady Willingdon State TB Centre, Bengaluru, Karnataka, India.
Reuben SwamickanTuberculosis and Infectious Diseases Division, USAID/India, New Delhi, India.
Amar ShahTuberculosis and Infectious Diseases Division, USAID/India, New Delhi, India.
K H PrakashKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Behind KSSIDC Admin. Office, Rajajinagar, Bengaluru, Karnataka, 560044, India.
Arin KarKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Behind KSSIDC Admin. Office, Rajajinagar, Bengaluru, Karnataka, 560044, India.
Karthikeyan KumaraswamyKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Behind KSSIDC Admin. Office, Rajajinagar, Bengaluru, Karnataka, 560044, India.
B S PrarthanaKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Behind KSSIDC Admin. Office, Rajajinagar, Bengaluru, Karnataka, 560044, India.
Bala Krishna MaryalaTB Alert India, Hyderabad, India.
J SushmaKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Behind KSSIDC Admin. Office, Rajajinagar, Bengaluru, Karnataka, 560044, India.
Ramesh DasariTB Alert India, Hyderabad, India.
Bharath ShettyKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Behind KSSIDC Admin. Office, Rajajinagar, Bengaluru, Karnataka, 560044, India.
Vikas PanibatlaTB Alert India, Hyderabad, India.
H L MohanKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Behind KSSIDC Admin. Office, Rajajinagar, Bengaluru, Karnataka, 560044, India.
Marissa BeckerDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Karnataka Health Promotion Trust · INNew Delhi Tuberculosis Center · INUniversity of Manitoba · CA

Funding

United States Agency for International Development AID-386-A-16-00005
6 · The paper itself

Abstract

backgroundTB is a preventable and treatable disease. Yet, successful treatment outcomes at desired levels are elusive in many national TB programs, including India. We aim to identify risk factors for unfavourable outcomes to TB treatment, in order to subsequently design a care model that would improve treatment outcomes among these at-risk patients.

methodsWe conducted a cohort analysis among TB patients who had been recently initiated on treatment. The study was part of the internal program evaluation of a USAID-THALI project, implemented in select towns/cities of Karnataka and Telangana, south India. Community Health Workers (CHWs) under the project, used a pre-designed tool to assess TB patients for potential risks of an unfavourable outcome. CHWs followed up this cohort of patients until treatment outcomes were declared. We extracted treatment outcomes from patient's follow-up data and from the Nikshay portal. The specific cohort of patients included in our study were those whose risk was assessed during July and September, 2018, subsequent to conceptualisation, tool finalisation and CHW training. We used bivariate and multivariate logistic regression to assess each of the individual and combined risks against unfavourable outcomes; death alone, or death, lost to follow up and treatment failure, combined as 'unfavourable outcome'.

resultsA significantly higher likelihood of death and experiencing unfavourable outcome was observed for individuals having more than one risk (AOR: 4.19; 95% CI: 2.47-7.11 for death; AOR 2.21; 95% CI: 1.56-3.12 for unfavourable outcome) or only one risk (AOR: 3.28; 95% CI: 2.11-5.10 for death; AOR 1.71; 95% CI: 1.29-2.26 for unfavourable outcome) as compared to TB patients with no identified risk. Male, a lower education status, an initial weight below the national median weight, co-existing HIV, previous history of treatment, drug-resistant TB, and regular alcohol use had significantly higher odds of death and unfavourable outcome, while age > 60 was only associated with higher odds of death.

conclusionA rapid risk assessment at treatment initiation can identify factors that are associated with unfavourable outcomes. TB programs could intensify care and support to these patients, in order to optimise treatment outcomes among TB patients.

Indexed as

Cohort StudiesDelivery of Health CareFemaleHumansIndiaMaleMiddle AgedModels, OrganizationalProgram EvaluationRisk FactorsTreatment FailureTreatment OutcomeTuberculosisDifferentiated careIndiaRisk-factorsTuberculosisUnfavourable outcomes

Identifiers

PMID32709228
PMCPMC7379762
OpenAlexW3045469633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.